Vimarsana
Biggest News Aggregation in the World

Page 15 - Clinical Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Application Today - Breaking & Trending Today

The Global Liquid Biopsy Market is Predicted to Reach US$ 9.53 Billion by 2028 - Vimarsana News

The Global Liquid Biopsy Market is Predicted to Reach US$ 9.53 Billion by 2028

/PRNewswire/ -- The "Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type,...

Liquid Biopsy Market Explores Massive Growth in Future - Vimarsana News

Liquid Biopsy Market Explores Massive Growth in Future

Liquid Biopsy Market Explores Massive Growth in Future

(단독)유바이오로직스, 코로나 백신 2상 투약 완료 - Vimarsana News

(단독)유바이오로직스, 코로나 백신 2상 투약 완료

유바이오로직스(206650)가 코로나19 백신 임상시험 2상 마무리 단계에 진입했다. 다음달 임상 ...

Predicting drug absorption in miniatured human liver - Vimarsana News

Predicting drug absorption in miniatured human liver

Kyoto University The Kazuo Takayama lab reports that PDMS-based liver-on-chip naturally absorb some drugs, which affects drug toxicity results. Liver-on-a-chip are miniaturized devices that capture the physiological and mechanical properties of the liver. They are commonly used by researchers to study how the liver metabolizes different compounds and drugs. In a new study seen in ACS Biomaterials Science & Engineering, CiRA Junior Associate Professor Kazuo Takayama and colleagues report which drugs based on their physicochemical properties are most suitable when using liver-on-a-chi...

Multiple immune reactions when transplanting cartilage into monkeys - Vimarsana News

Multiple immune reactions when transplanting cartilage into monkeys

Kyoto University The Noriyuki Tsumaki lab reports the effects of gene editing monkey iPS cells on regenerative medicine for damaged knee cartilage. Immune rejection is one of the biggest obstacles to a cell therapy. To solve this problem, researchers have been investigating iPS cells that have been gene edited so that they can evade the immune system. While this concept is theoretically possible, there is limited evidence that it works in species resembling humans. A new study by the laboratory of CiRA Professor Noriyuki Tsumaki shows that this strategy is more complicated than ex...